Quince Therapeutics Commercial Paper Liability (Annual Per Share) Trends

Quince Therapeutics, Inc. (QNCX)

0.1023 -0.01 (-6.49%) USD | NASDAQ | Mar 06, 16:00

0.1025 0.00 (0.00%) Pre-Market: 20:00

View Commercial Paper Liability (Annual Per Share) for QNCX.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Commercial Paper Liability (Annual Per Share) Chart

Start Trial

View Historical Data

Start Trial

View Commercial Paper Liability (Annual Per Share) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Commercial Paper Liability (Annual Per Share) Benchmarks

Start Trial

Recursion Pharmaceuticals, Inc.	--
Ocular Therapeutix, Inc.	--
BioXcel Therapeutics, Inc.	--
Gossamer Bio, Inc.	--
Ernexa Therapeutics, Inc.	--